{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:09:17Z","timestamp":1794006557125,"version":"4.8.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To assess pregnancy risk after intrauterine device (IUD) placement by the number and timing of unprotected intercourse episodes in the prior 14 days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>This was a secondary analysis of a randomized trial that compared the copper T380A IUD and levonorgestrel 52-mg intrauterine system for emergency contraception. At enrollment, participants had a negative urine pregnancy test result and reported the frequency and timing of any unprotected intercourse in the preceding 14 days. We assessed pregnancies 1 month after IUD placement and compared pregnancy risk by single or multiple unprotected intercourse episodes and by timing (5 or fewer days before IUD placement or 6 or more days before).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Among the 655 participants, one pregnancy occurred in a patient who reported intercourse once 48 hours before IUD placement. Multiple unprotected intercourse episodes were reported by 286 participants (43.7%), and 95 participants (14.4%) reported at least one unprotected intercourse episode 6 or more days before IUD placement. No pregnancies occurred among those with multiple unprotected intercourse episodes (0%, 97.5% CI 0\u20131.3%) or with any unprotected intercourse episode 6\u201314 days before IUD placement (0.0%, 97.5% CI 0.0\u20133.8%). Pregnancy risk difference did not significantly differ by single compared with multiple unprotected intercourse episodes (0.3%, 95% CI \u22120.3% to 0.8%), nor by unprotected intercourse 5 or fewer days before IUD placement or 6 or more days before (0.2%, 95% CI \u22120.2% to 0.5%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>With a negative urine pregnancy test result at IUD placement, 1-month pregnancy risk remains low, regardless of frequency or timing of unprotected intercourse in the prior 14 days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical Trial Registration:<\/jats:title>\n            <jats:p>\n                                 ClinicalTrials.gov, NCT02175030.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000004433","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T01:03:25Z","timestamp":1624496605000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception"],"prefix":"10.1097","volume":"138","author":[{"given":"Abena","family":"BakenRa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Turok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"R1-20250430","doi-asserted-by":"crossref","first-page":"592.e1","DOI":"10.1016\/j.ajog.2016.06.028","article-title":"Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception","volume":"215","author":"Sanders","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20250430","first-page":"1","article-title":"U.S. Medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R4-20250430","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/01.AOG.0000239440.02284.45","article-title":"Progesterone receptor modulator for emergency contraception: a randomized controlled trial","volume":"108","author":"Creinin","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R5-20250430","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(02)11767-3","article-title":"Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial","volume":"360","author":"von Hertzen","year":"2002","journal-title":"Lancet"},{"key":"R6-20250430","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa2022141","article-title":"The levonorgestrel vs. Copper intrauterine device for emergency contraception","volume":"384","author":"Turok","year":"2021","journal-title":"N Engl J Med"},{"key":"R7-20250430","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis","volume":"375","author":"Glasier","year":"2010","journal-title":"Lancet"},{"key":"R8-20250430","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.contraception.2019.05.015","article-title":"Copper intrauterine device placement 6-14 days after unprotected sex","volume":"100","author":"Thompson","year":"2019","journal-title":"Contraception"},{"key":"R9-20250430","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/AOG.0000000000004118","article-title":"Risk of pregnancy with levonorgestrel-releasing intrauterine system placement 6-14 days after unprotected sexual intercourse","volume":"137","author":"Boraas","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R10-20250430","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1701-2163(16)30033-0","article-title":"Canadian contraception consensus (Part 1 of 4)","volume":"37","author":"Black","year":"2015","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T06:50:06Z","timestamp":1746082206000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004433","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"2021-02-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}